LEVOTHYROXINE SODIUM /25mcg; 50mcg; 75mcg; 100mcg; 125mcg; 150mcg; 200mcg Tablet
Product Description
ABDI IBRAHIM ILAC SAN. VE TIC. A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
Categories
ABDI IBRAHIM ILAC SAN. VE TIC. A.S.
-
TR
-
2015On CPHI since
-
3Certificates
-
1000 - 4999Employees
Company types
More Products from ABDI IBRAHIM ILAC SAN. VE TIC. A.S. (99)
-
Product Oroheks Plus Oral Sprey
Oroheks plus oral sprey belongs to the respiratory system category It is used for antiinflammatory, antiseptic Form: oral sprey Active substances: 0,15 % benzydamine hcl, 0,12 % klorhexidine gluconate Package type: 30 ml glass bottle with oral applicator Licensor: tripharma -
Product Osteomax Tablet 70 mg
Osteomax tablet 70 mg belongs to the endocrine and metabolism category It is used for bone calcium regulators Form: tablets Active substances: alendronate sodium 9135 mg/ tablet Package type: alu/alu blister packs of 4 tablets Licensor: abdi ibrahim ilaç -
Product DICLOFENAC /50 mg Tablet
Non-Steroidal Antirheumatics -
Product ACETYLSALICYLIC ACID /100 mg Enteric Coated Tablet
Platelet aggregation inhibitors (COX inhibitors) -
Product OLANZAPINE /2.5 mg & 5 mg & 10 mg & 20 mg Tablet
Atypical Antipsychotics - Schizophrenia -
Product FLUTICASONE + SALMETEROL /50 mcg/100mcg Dry Powder Inhaler
Adrenergics (B2 agonists) in combination with corticosteroids - Asthma & COPD -
Product LEVETIRACETAM / 500 mg & 750 mg & 1000 mg Tablet
Antiepileptic -
Product TADALAFIL / 5mg; 10mg; 20mg Tablet
PDE5 Inhibitors - Erectile dysfunction -
Product ESCITALOPRAM / 5 mg; 10 mg; 20 mg Tablet; 10 mg/ml oral drops
Selective serotonin reuptake inhibitors - Antidepressants -
Product ENTECAVIR / 0,5 mg; 1 mg Tablet
Nucleoside reverse transcriptase inhibitors (NRTI) - Hepatitis B -
Product TENOFOVIR DISOPROXIL / 245 mg Tablet
Nucleoside reverse transcriptase inhibitors (NRTI) - Hepatitis B
ABDI IBRAHIM ILAC SAN. VE TIC. A.S. resources (2)
-
News Abdi İbrahim Receives 'Equal Opportunity Model' Certificate for Women's Employment
Abdi İbrahim has been awarded the 'Equal Opportunity Model' (FEM) certificate, developed by KAGIDER with the technical support of the World Bank, to promote gender equality in business life and enhance women's productivity. Deniz Daver, President of Human and Culture Group, expressed their happiness in receiving this certificate, stating, “This certificate, which acknowledges companies' sensitive approaches to gender equality and women's empowerment in employment, is an important indicator reflecting Abdi İbrahim's vision of inclusiveness. We see FEM certificate as a reward for our determined and continuous efforts in this field. -
Brochure HEALING THE LIVES, HEALING THE FUTURE THAT’S WHAT WE DO.
Turkish pharmaceutical industry leader Abdi Ibrahim s journey began in 1912.In addition to its partnerships with more than 30 licensing firms across the globe, Abdi Ibrahim develops its own products with 250 brands and 500 products.Abdi Ibrahim has subsidiaries operating in 17 countries outside Turkey, exports to more than 70 countries from the European Union to Canada, North Africa to Asia and generates the highest employment rate in the Turkish pharmaceutical industry with 5500 qualified employees.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance